ni2o RapidTest

Countering Communicable Diseases with our Five-Minute Test

Worldwide Testing Challenges

COVID-19 has opened our eyes to the many communities who don’t have adequate disease detection technology. Ni2o’s RapidTest instrument will allow for a variety of diseases to be detected from samples collected via a non-invasive method, removing the need for specialized testing equipment and personnel.

While we hope to not endure something as devastating as COVID-19 in the near future, another pandemic may be inevitable. A lag in testing can overwhelm labs and hospitals, allowing a contagious disease to spread almost undetected.

Quick Point-of-Care (POC) testing is crucial for ensuring lower pathogen transmissibility. That is why ni2o is beginning development on cartridges to address common diseases such as Influenza A/B, HIV, and Hepatitis.

Robust Testing System

ni2o RapidTest is a comprehensive coronavirus detection system that is portable and non-invasive.
With deep integration and ease of use, ni2o RapidTest is a powerful tool in pandemic mitigation and management of future outbreaks.

Tests can be performed without trained professionals, reducing exposure

Personnel

Tests can be performed without trained professionals, reducing exposure

ni2o Rapid Test results are available within 5 minutes or less

Speed

Test results are available within 5 minutes or less

Non-invasive sample collection using saliva

Samples

Non-invasive sample collection using saliva

ni2o Rapid Test can be done at home, at a doctor’s office, or at schools and workplaces

Setting

Tests can be done at home, at a doctor’s office, or at schools and workplaces

Device can communicate results via USB, allowing rich integration

Integration

Device can communicate results via USB, allowing rich integration

The Need for Speed

Rapid testing for antibodies and viral load, detecting exposure, and assessing risk within minutes will provide benefits throughout the healthcare ecosystem.

ni2o RapidTest provides rapid and scalable screenings of populations to understand immunity and enable timely, sustainable national and global responses.

Flatten the Curve

Our test quickly produces results with high accuracy and detects exposure in asymptomatic carriers, patients who are visibly ill, and those who were infected with COVID-19 in the past. Easy and affordable in-home, school, and workplace testing allows for informed, effective self-isolation and quarantine protocols.

Want to learn more about our test?